Cited by 59Receptor Mechanisms and SignalingNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

Cardiac and neuroprotection regulated by α1-adrenergic receptor subtypes

Open access
Perez, Dianne M., Doze, Van A.·2011·Journal of Receptors and Signal Transduction

Abstract

Sympathetic nervous system regulation by the α(1)-adrenergic receptor (AR) subtypes (α(1A), α(1B), α(1D)) is complex, whereby chronic activity can be either detrimental or protective for both heart and brain function. This review will summarize the evidence that this dual regulation can be mediated through the different α(1)-AR subtypes in the context of cardiac hypertrophy, heart failure, apoptosis, ischemic preconditioning, neurogenesis, locomotion, neurodegeneration, cognition, neuroplasticity, depression, anxiety, epilepsy, and mental illness.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/10799893.2010.550008

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Terazosin has a proconvulsant effect via antagonizing α1-adrenergic receptor.

    “Considering the proconvulsant effect of terazosin via antagonizing α1-adrenergic receptor (Chen et al., 2007; Perez and Doze, 2011)”

    From APOE4 reduces hippocampal expression of phosphoglycerate kinase 1 and sodium potassium pump to enhance seizure susceptibility in mice (2026) · cites this paper as Perez and Doze, 2011

    The Neurophysiology section (‘α1A-ARs in epilepsy’; page unavailable) says α1-receptor activity can mediate anticonvulsant effects and that α1A-receptor knockout mice often have spontaneous seizures. It does not report that terazosin is proconvulsant or establish that terazosin causes seizures by antagonizing α1 receptors; a search for terazosin found no relevant passage. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 187

  1. [1]Graham RM Lanier SM Fozzard HA Identification and characterization of alpha- adrenergic receptors chapter 50 The Heart, and Cardiovascular System 1986 New York Raven Press 1059 1095
  2. [2]Ahlquist RP A study of the adrenotropic receptors Am J Physiol 1948 153 586 600 18882199
  3. [3]Morrow AL Creese I Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding Mol Pharmacol 1986 29 321 330 3010073
  4. [4]Cotecchia S Schwinn DA Randall RR Lefkowitz RJ Caron MG Kobilka BK Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor Proc Natl Acad Sci USA 1988 85 7159 7163 2845398 PMC282143
  5. [5]Schwinn DA Lomasney JW Lorenz W Szklut PJ Fremeau RT Jr Yang-Feng TL Caron MG Lefkowitz RJ Cotecchia S Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype J Biol Chem 1990 265 8183 8189 1970822
  6. [6]Perez DM Piascik MT Malik N Gaivin R Graham RM Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype Mol Pharmacol 1994 46 823 831 7969068
  7. [7]Laz TM Forray C Smith KE Bard JA Vaysse PJ Branchek TA Weinshank RL The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype Mol Pharmacol 1994 46 414 422 7935320
  8. [8]Lomasney JW Cotecchia S Lorenz W Leung WY Schwinn DA Yang-Feng TL Brownstein M Lefkowitz RJ Caron MG Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5 J Biol Chem 1991 266 6365 6369 1706716
  9. [9]Perez DM Piascik MT Graham RM Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA Mol Pharmacol 1991 40 876 883 1661838
  10. [10]Hieble JP Bylund DB Clarke DE Eikenburg DC Langer SZ Lefkowitz RJ Minneman KP Ruffolo RR Jr International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update Pharmacol Rev 1995 47 267 270 7568329
  11. [11]Rokosh DG Bailey BA Stewart AF Karns LR Long CS Simpson PC Distribution of alpha 1C-adrenergic receptor mRNA in adult rat tissues by RNase protection assay and comparison with alpha 1B and alpha 1D Biochem Biophys Res Commun 1994 200 1177 1184 8185565
  12. [12]Scofield MA Liu F Abel PW Jeffries WB Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction J Pharmacol Exp Ther 1995 275 1035 1042 7473130
  13. [13]Bürger A Benicke M Deten A Zimmer HG Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts Am J Physiol Heart Circ Physiol 2001 281 H14 H21 11406463
  14. [14]Lai KB Sanderson JE Yu CM Suppression of collagen production in norepinephrine stimulated cardiac fibroblasts culture: differential effect of alpha and beta-adrenoreceptor antagonism Cardiovasc Drugs Ther 2009 23 271 280 19575289
  15. [15]Böhm M Diet F Feiler G Kemkes B Erdmann E Alpha-adrenoceptors and alpha-adrenoceptor-mediated positive inotropic effects in failing human myocardium J Cardiovasc Pharmacol 1988 12 357 364 2464110
  16. [16]Landzberg JS Parker JD Gauthier DF Colucci WS Effects of myocardial alpha 1-adrenergic receptor stimulation and blockade on contractility in humans Circulation 1991 84 1608 1614 1655303
  17. [17]Skomedal T Borthne K Aass H Geiran O Osnes JB Comparison between alpha-1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle J Pharmacol Exp Ther 1997 280 721 729 9023284
  18. [18]Wang H Yang B Zhang Y Han H Wang J Shi H Wang Z Different subtypes of alpha1-adrenoceptor modulate different K+ currents via different signaling pathways in canine ventricular myocytes J Biol Chem 2001 276 40811 40816 11524420
  19. [19]O-Uchi J Sasaki H Morimoto S Kusakari Y Shinji H Obata T Hongo K Komukai K Kurihara S Interaction of α1-adrenoceptor subtypes with different G proteins induces opposite effects on cardiac L-type Ca2+ channel Circ Res 2008 102 1378 1388 18467629
  20. [21]Meidell RS Sen A Henderson SA Slahetka MF Chien KR Alpha 1-adrenergic stimulation of rat myocardial cells increases protein synthesis Am J Physiol 1986 251 H1076 H1084 3022607
  21. [22]Long CS Kariya K Karns L Simpson PC Sympathetic modulation of the cardiac myocyte phenotype: studies with a cell-culture model of myocardial hypertrophy Basic Res Cardiol 1992 87 Suppl 2 19 31 1338564
  22. [23]Selvetella G Hirsch E Notte A Tarone G Lembo G Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence Cardiovasc Res 2004 63 373 380 15276462
  23. [24]Autelitano DJ Woodcock EA Selective activation of alpha1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha1- adrenergic receptor subtype mRNAs J Mol Cell Cardiol 1998 30 1515 1523 9737938
  24. [25]Knowlton KU Michel MC Itani M Shubeita HE Ishihara K Brown JH Chien KR The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy J Biol Chem 1993 268 15374 15380 8393439
  25. [26]Rorabaugh BR Ross SA Gaivin RJ Papay RS McCune DF Simpson PC Perez DM alpha1A— but not alpha1B—adrenergic receptors precondition the ischemic heart by a staurosporinesensitive, chelerythrine-insensitive mechanism Cardiovasc Res 2005 65 436 445 15639483
  26. [27]Lin F Owens WA Chen S Stevens ME Kesteven S Arthur JF Woodcock EA Feneley MP Graham RM Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy Circ Res 2001 89 343 350 11509451
  27. [28]Du XJ Gao XM Kiriazis H Moore XL Ming Z Su Y Finch AM Hannan RA Dart AM Graham RM Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival Cardiovasc Res 2006 71 735 743 16859660
  28. [29]Chaulet H Lin F Guo J Owens WA Michalicek J Kesteven SH Guan Z Prall OW Mearns BM Feneley MP Steinberg SF Graham RM Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes J Mol Cell Cardiol 2006 40 540 552 16516910
  29. [30]Kunisada K Tone E Fujio Y Matsui H Yamauchi-Takihara K Kishimoto T Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes Circulation 1998 98 346 352 9711940
  30. [31]Hirota H Chen J Betz UA Rajewsky K Gu Y Ross J Jr Müller W Chien KR Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress Cell 1999 97 189 198 10219240
  31. [32]Kunisada K Negoro S Tone E Funamoto M Osugi T Yamada S Okabe M Kishimoto T Yamauchi-Takihara K Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicininduced cardiomyopathy Proc Natl Acad Sci USA 2000 97 315 319 10618415 PMC26660
  32. [33]Jacoby JJ Kalinowski A Liu MG Zhang SS Gao Q Chai GX Ji L Iwamoto Y Li E Schneider M Russell KS Fu XY Cardiomyocyterestricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age Proc Natl Acad Sci USA 2003 100 12929 12934 14566054 PMC240721
  33. [34]Milano CA Dolber PC Rockman HA Bond RA Venable ME Allen LF Lefkowitz RJ Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy Proc Natl Acad Sci USA 1994 91 10109 10113 7937846 PMC44967
  34. [35]Wang BH Du XJ Autelitano DJ Milano CA Woodcock EA Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts Am J Physiol Heart Circ Physiol 2000 279 H1079 H1086 10993770
  35. [36]Grupp IL Lorenz JN Walsh RA Boivin GP Rindt H Overexpression of alpha1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy Am J Physiol 1998 275 H1338 H1350 9746484
  36. [37]Benoit MJ Rindt H Allen BG Cardiac-specific transgenic overexpression of alpha1B-adrenergic receptors induce chronic activation of ERK MAPK signalling Biochem Cell Biol 2004 82 719 727 15674439
  37. [38]Akhter SA Milano CA Shotwell KF Cho MC Rockman HA Lefkowitz RJ Koch WJ Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1- adrenergic receptor-mediated regulation of beta-adrenergic signaling J Biol Chem 1997 272 21253 21259 9261135
  38. [39]Iaccarino G Keys JR Rapacciuolo A Shotwell KF Lefkowitz RJ Rockman HA Koch WJ Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors J Am Coll Cardiol 2001 38 534 540 11499749
  39. [40]Zuscik MJ Chalothorn D Hellard D Deighan C McGee A Daly CJ Waugh DJ Ross SA Gaivin RJ Morehead AJ Thomas JD Plow EF McGrath JC Piascik MT Perez DM Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the alpha 1B-adrenergic receptor J Biol Chem 2001 276 13738 13743 11278430
  40. [41]Vecchione C Fratta L Rizzoni D Notte A Poulet R Porteri E Frati G Guelfi D Trimarco V Mulvany MJ Agabiti-Rosei E Trimarco B Cotecchia S Lembo G Cardiovascular influences of alpha1b-adrenergic receptor defect in mice Circulation 2002 105 1700 1707 11940550
  41. [42]Bristow MR Ginsburg R Gilbert EM Hershberger RE Heterogeneous regulatory changes in cell surface membrane receptors coupled to a positive inotropic response in the failing human heart Basic Res Cardiol 1987 82 Suppl 2 369 376 2821984
  42. [43]Steinfath M Danielsen W von der Leyen H Mende U Meyer W Neumann J Nose M Reich T Schmitz W Scholz H Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure Br J Pharmacol 1992 105 463 469 1348446 PMC1908677
  43. [44]Iwai-Kanai E Hasegawa K Araki M Kakita T Morimoto T Sasayama S alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes Circulation 1999 100 305 311 10411857
  44. [45]Brodde OE Beta- and alpha-adrenoceptor-agonists and -antagonists in chronic heart failure Basic Res Cardiol 1990 85 Suppl 1 57 66 1965405
  45. [46]ALLHAT Collaborative Research Group Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) JAMA 2000 283 1967 1975 10789664
  46. [47]Koshimizu TA Tsujimoto G Hirasawa A Kitagawa Y Tanoue A Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors Cardiovasc Res 2004 63 662 672 15306222
  47. [48]Varma DR Rindt H Chemtob S Mulay S Mechanism of the negative inotropic effects of alpha 1-adrenoceptor agonists on mouse myocardium Can J Physiol Pharmacol 2003 81 783 789 12897807
  48. [49]Varma DR Deng XF Cardiovascular alpha1-adrenoceptor subtypes: functions and signaling Can J Physiol Pharmacol 2000 78 267 292 10772055
  49. [50]Wang GY McCloskey DT Turcato S Swigart PM Simpson PC Baker AJ Contrasting inotropic responses to alpha1-adrenergic receptor stimulation in left versus right ventricular myocardium Am J Physiol Heart Circ Physiol 2006 291 H2013 H2017 16731650
  50. [51]Wang GY Yeh CC Jensen BC Mann MJ Simpson PC Baker AJ Heart failure switches the RV alpha1-adrenergic inotropic response from negative to positive Am J Physiol Heart Circ Physiol 2010 298 H913 H920 20035030 PMC2838546
  51. [52]Jensen BC Swigart PM De Marco T Hoopes C Simpson PC {alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium Circ Heart Fail 2009 2 654 663 19919991 PMC2780440
  52. [53]Grigore A Poindexter B Vaughn WK Nussmeier N Frazier OH Cooper JR Gregoric ID Buja LM Bick RJ Alterations in alpha adrenoreceptor density and localization after mechanical left ventricular unloading with the Jarvik flowmaker left ventricular assist device J Heart Lung Transplant 2005 24 609 613 15896760
  53. [54]O’Connell TD Swigart PM Rodrigo MC Ishizaka S Joho S Turnbull L Tecott LH Baker AJ Foster E Grossman W Simpson PC Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload J Clin Invest 2006 116 1005 1015 16585965 PMC1421341
  54. [55]Du XJ Fang L Gao XM Kiriazis H Feng X Hotchkin E Finch AM Chaulet H Graham RM Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction J Mol Cell Cardiol 2004 37 979 987 15522275
  55. [56]Ross SA Rorabaugh BR Chalothorn D Yun J Gonzalez-Cabrera PJ McCune DF Piascik MT Perez DM The alpha(1B)-adrenergic receptor decreases the inotropic response in the mouse Langendorff heart model Cardiovasc Res 2003 60 598 607 14659805
  56. [57]Lemire I Ducharme A Tardif JC Poulin F Jones LR Allen BG Hébert TE Rindt H Cardiac-directed overexpression of wild-type alpha1B-adrenergic receptor induces dilated cardiomyopathy Am J Physiol Heart Circ Physiol 2001 281 H931 H938 11454600
  57. [58]Rivard K Trépanier-Boulay V Rindt H Fiset C Electrical remodeling in a transgenic mouse model of alpha1B-adrenergic receptor overexpression Am J Physiol Heart Circ Physiol 2009 296 H704 H718 19112097
  58. [59]Du XJ Distinct role of adrenoceptor subtypes in cardiac adaptation to chronic pressure overload Clin Exp Pharmacol Physiol 2008 35 355 360 18290877
  59. [60]Rona G Catecholamine cardiotoxicity J Mol Cell Cardiol 1985 17 291 306 3894676
  60. [61]Mann DL Kent RL Parsons B Cooper G 4th Adrenergic effects on the biology of the adult mammalian cardiocyte Circulation 1992 85 790 804 1370925
  61. [62]Singh K Communal C Colucci WS Inhibition of protein phosphatase 1 induces apoptosis in neonatal rat cardiac myocytes: role of adrenergic receptor stimulation Basic Res Cardiol 2000 95 389 396 11099166
  62. [63]Baghelai K Graham LJ Wechsler AS Jakoi ER Delayed myocardial preconditioning by alpha1-adrenoceptors involves inhibition of apoptosis J Thorac Cardiovasc Surg 1999 117 980 986 10220693
  63. [64]Huang Y Wright CD Merkwan CL Baye NL Liang Q Simpson PC O’Connell TD An alpha1A-adrenergic-extracellular signalregulated kinase survival signaling pathway in cardiac myocytes Circulation 2007 115 763 772 17283256
  64. [65]Adams JW Sakata Y Davis MG Sah VP Wang Y Liggett SB Chien KR Brown JH Dorn GW 2nd Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure Proc Natl Acad Sci USA 1998 95 10140 10145 9707614 PMC21475
  65. [66]Hilal-Dandan R Kanter JR Brunton LL Characterization of G-protein signaling in ventricular myocytes from the adult mouse heart: differences from the rat J Mol Cell Cardiol 2000 32 1211 1221 10860764
  66. [67]Steinberg SF Drugge ED Bilezikian JP Robinson RB Acquisition by innervated cardiac myocytes of a pertussis toxin-specific regulatory protein linked to the alpha 1-receptor Science 1985 230 186 188 2994230
  67. [68]Rorabaugh BR Gaivin RJ Papay RS Shi T Simpson PC Perez DM Both alpha(1A)- and alpha(1B)-adrenergic receptors crosstalk to down regulate beta(1)-ARs in mouse heart: coupling to differential PTX-sensitive pathways J Mol Cell Cardiol 2005 39 777 784 16171811
  68. [69]Kurz T Yamada KA DaTorre SD Corr PB Alpha 1-adrenergic system and arrhythmias in ischaemic heart disease Eur Heart J 1991 12 Suppl F 88 98 1666558
  69. [70]Bankwala Z Hale SL Kloner RA Alpha-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning Circulation 1994 90 1023 1028 8044915
  70. [71]Banerjee A Locke-Winter C Rogers KB Mitchell MB Brew EC Cairns CB Bensard DD Harken AH Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism Circ Res 1993 73 656 670 8396503
  71. [72]Hu K Nattel S Mechanisms of ischemic preconditioning in rat hearts. Involvement of alpha 1B-adrenoceptors, pertussis toxinsensitive G proteins, and protein kinase C Circulation 1995 92 2259 2265 7554210
  72. [73]Kariya T Minatoguchi S Ohno T Yamashita K Uno Y Arai M Koshiji M Fujiwara T Fujiwara H Infarct size-reducing effect of ischemic preconditioning is related to alpha1b-adrenoceptors but not to alpha1a-adrenoceptors in rabbits J Cardiovasc Pharmacol 1997 30 437 445 9335402
  73. [74]Gao H Chen L Yang HT Activation of alpha1B-adrenoceptors alleviates ischemia/reperfusion injury by limitation of mitochondrial Ca2+ overload in cardiomyocytes Cardiovasc Res 2007 75 584 595 17509549
  74. [75]Xiao L Jeffries WB Kinetics of alkylation of cloned rat alpha1-adrenoceptor subtypes by chloroethylclonidine Eur J Pharmacol 1998 347 319 327 9653899
  75. [76]Amirahmadi F Turnbull L Du XJ Graham RM Woodcock EA Heightened alpha1A-adrenergic receptor activity suppresses ischaemia/reperfusion-induced Ins(1,4,5)P3 generation in the mouse heart: a comparison with ischaemic preconditioning Clin Sci 2008 114 157 164 17696883
  76. [77]Gao XM Wang BH Woodcock E Du XJ Expression of active alpha(1B)-adrenergic receptors in the heart does not alleviate ischemic reperfusion injury J Mol Cell Cardiol 2000 32 1679 1686 10966830
  77. [78]Sah VP Hoshijima M Chien KR Brown JH Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways J Biol Chem 1996 271 31185 31190 8940118
  78. [79]Hines WA Thorburn A Ras and rho are required for Galphaqinduced hypertrophic gene expression in neonatal rat cardiac myocytes J Mol Cell Cardiol 1998 30 485 494 9515026
  79. [80]Appert-Collin A Cotecchia S Nenniger-Tosato M Pedrazzini T Diviani D The A-kinase anchoring protein (AKAP)-Lbcsignaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy Proc Natl Acad Sci USA 2007 104 10140 10145 17537920 PMC1891209
  80. [81]Ramirez MT Sah VP Zhao XL Hunter JJ Chien KR Brown JH The MEKK–JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy J Biol Chem 1997 272 14057 14061 9162028
  81. [82]Sakata Y Hoit BD Liggett SB Walsh RA Dorn GW 2nd Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice Circulation 1998 97 1488 1495 9576430
  82. [83]D’Angelo DD Sakata Y Lorenz JN Boivin GP Walsh RA Liggett SB Dorn GW 2nd Transgenic Galphaq overexpression induces cardiac contractile failure in mice Proc Natl Acad Sci USA 1997 94 8121 8126 9223325 PMC21567
  83. [84]Gottshall KR Hunter JJ Tanaka N Dalton N Becker KD Ross J Jr Chien KR Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice Proc Natl Acad Sci USA 1997 94 4710 4715 9114056 PMC20789
  84. [85]Hunter JJ Tanaka N Rockman HA Ross J Jr Chien KR Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice J Biol Chem 1995 270 23173 23178 7559464
  85. [86]Xiao L Pimental DR Amin JK Singh K Sawyer DB Colucci WS MEK1/2–ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes J Mol Cell Cardiol 2001 33 779 787 11273730
  86. [87]Wang L Proud CG Ras/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes Circ Res 2002 91 821 829 12411397
  87. [88]Wenham D Rahmatullah RJ Rahmatullah M Hansen CA Robishaw JD Differential coupling of alpha1-adrenoreceptor subtypes to phospholipase C and mitogen activated protein kinase in neonatal rat cardiac myocytes Eur J Pharmacol 1997 339 77 86 9450619
  88. [89]Davidson SM Townsend PA Carroll C Yurek-George A Balasubramanyam K Kundu TK Stephanou A Packham G Ganesan A Latchman DS The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin Chembiochem 2005 6 162 170 15593114
  89. [90]Rojas Gomez DM Schulte JS Mohr FW Dhein S Alpha-1-adrenoceptor subtype selective regulation of connexin 43 expression in rat cardiomyocytes Naunyn Schmiedebergs Arch Pharmacol 2008 377 77 85 18193202
  90. [91]Morris JB Kenney B Huynh H Woodcock EA Regulation of the proapoptotic factor FOXO1 (FKHR) in cardiomyocytes by growth factors and alpha1-adrenergic agonists Endocrinology 2005 146 4370 4376 16020479
  91. [93]Wang Y Ashraf M Activation of alpha1-adrenergic receptor during Ca2+ pre-conditioning elicits strong protection against Ca2+ overload injury via protein kinase C signaling pathway J Mol Cell Cardiol 1998 30 2423 2435 9925377
  92. [94]Pucéat M Hilal-Dandan R Strulovici B Brunton LL Brown JH Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes J Biol Chem 1994 269 16938 16944 8207017
  93. [95]Guo J Sabri A Elouardighi H Rybin V Steinberg SF Alpha1- adrenergic receptors activate AKT via a Pyk2/PDK-1 pathway that is tonically inhibited by novel protein kinase C isoforms in cardiomyocytes Circ Res 2006 99 1367 1375 17110596
  94. [96]Meng X Brown JM Ao L Banerjee A Harken AH Norepinephrine induces cardiac heat shock protein 70 and delayed cardioprotection in the rat through alpha 1 adrenoceptors Cardiovasc Res 1996 32 374 383 8796125
  95. [97]Lacoste A De Cian MC Cueff A Poulet SA Noradrenaline and alpha-adrenergic signaling induce the hsp70 gene promoter in mollusc immune cells J Cell Sci 2001 114 3557 3564 11682614
  96. [98]Takahashi Y Takemura S Minamiyama Y Shibata T Hirai H Sasaki Y Sakaguchi M Suehiro S Landiolol has cardioprotective effects against reperfusion injury in the rat heart via the PKCepsilon signaling pathway Free Radic Res 2007 41 757 769 17577736
  97. [99]Serejo FC Rodrigues LF Jr da Silva Tavares KC de Carvalho AC Nascimento JH Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning J Cardiovasc Pharmacol 2007 49 214 220 17438406
  98. [100]Foody JM Farrell MH Krumholz HM beta-Blocker therapy in heart failure: scientific review JAMA 2002 287 883 889 11851582
  99. [101]Iversen LL Iversen SD Bloom FE Roth RH Catecholamines Introduction to Neuropsychopharmacology 2009 New York Oxford University Press 150 213
  100. [102]Ordway GA Schwartz MA Frazer A Part III. Norepinephrine and behavioral Brain Norepinephrine 2007 Cambridge Cambridge University Press 157 298
  101. [103]Ordway GA Schwartz MA Frazer A Part III. The biology of norepinephrine in CNS pathology Brain Norepinephrine 2007 Cambridge Cambridge University Press 299 514
  102. [104]Unnerstall JR Fernandez I Orensanz LM The alpha-adrenergic receptor: radiohistochemical analysis of functional characteristics and biochemical differences Pharmacol Biochem Behav 1985 22 859 874 2989949
  103. [105]Domyancic AV Morilak DA Distribution of alpha1A adrenergic receptor mRNA in the rat brain visualized by in situ hybridization J Comp Neurol 1997 386 358 378 9303423
  104. [107]Palacios JM Hoyer D Cortés R alpha 1-Adrenoceptors in the mammalian brain: similar pharmacology but different distribution in rodents and primates Brain Res 1987 419 65 75 2823969
  105. [108]Zilles K Gross G Schleicher A Schildgen S Bauer A Bahro M Schwendemann G Zech K Kolassa N Regional and laminar distributions of alpha 1-adrenoceptors and their subtypes in human and rat hippocampus Neuroscience 1991 40 307 320 1674110
  106. [109]Papay R Gaivin R McCune DF Rorabaugh BR Macklin WB McGrath JC Perez DM Mouse alpha1B-adrenergic receptor is expressed in neurons and NG2 oligodendrocytes J Comp Neurol 2004 478 1 10 15334645
  107. [110]Papay R Gaivin R Jha A McCune DF McGrath JC Rodrigo MC Simpson PC Doze VA Perez DM Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors J Comp Neurol 2006 497 209 222 16705673
  108. [111]Rokosh DG Simpson PC Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure Proc Natl Acad Sci USA 2002 99 9474 9479 12093905 PMC123165
  109. [112]Cavalli A Lattion AL Hummler E Nenniger M Pedrazzini T Aubert JF Michel MC Yang M Lembo G Vecchione C Mostardini M Schmidt A Beermann F Cotecchia S Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor Proc Natl Acad Sci USA 1997 94 11589 11594 9326654 PMC23548
  110. [113]Tanoue A Nasa Y Koshimizu T Shinoura H Oshikawa S Kawai T Sunada S Takeo S Tsujimoto G The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction J Clin Invest 2002 109 765 775 11901185 PMC150908
  111. [114]Mouradian RD Sessler FM Waterhouse BD Noradrenergic potentiation of excitatory transmitter action in cerebrocortical slices: evidence for mediation by an alpha 1 receptor-linked second messenger pathway Brain Res 1991 546 83 95 1677306
  112. [115]Gordon GR Bains JS Priming of excitatory synapses by alpha1 adrenoceptor-mediated inhibition of group III metabotropic glutamate receptors J Neurosci 2003 23 6223 6231 12867506 PMC6740556
  113. [116]Marek GJ Aghajanian GK Alpha 1B-adrenoceptor-mediated excitation of piriform cortical interneurons Eur J Pharmacol 1996 305 95 100 8813537
  114. [117]Hirono M Obata K Alpha-adrenoceptive dual modulation of inhibitory GABAergic inputs to Purkinje cells in the mouse cerebellum J Neurophysiol 2006 95 700 708 16251261
  115. [118]Chen Q Li DP Pan HL Presynaptic alpha1 adrenergic receptors differentially regulate synaptic glutamate and GABA release to hypothalamic presympathetic neurons J Pharmacol Exp Ther 2006 316 733 742 16249372
  116. [120]Bergles DE Doze VA Madison DV Smith SJ Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons J Neurosci 1996 16 572 585 8551341 PMC6578664
  117. [121]Kulik A Haentzsch A Lückermann M Reichelt W Ballanyi K Neuron-glia signaling via alpha(1) adrenoceptor-mediated Ca(2+) release in Bergmann glial cells in situ J Neurosci 1999 19 8401 8408 10493741 PMC6783004
  118. [122]Malberg JE Eisch AJ Nestler EJ Duman RS Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J Neurosci 2000 20 9104 9110 11124987 PMC6773038
  119. [123]Kulkarni VA Jha S Vaidya VA Depletion of norepinephrine decreases the proliferation, but does not influence the survival and differentiation, of granule cell progenitors in the adult rat hippocampus Eur J Neurosci 2002 16 2008 2012 12453065
  120. [124]Hiramoto T Ihara Y Watanabe Y alpha-1 Adrenergic receptors stimulation induces the proliferation of neural progenitor cells in vitro Neurosci Lett 2006 408 25 28 16989945
  121. [125]Hiramoto T Satoh Y Takishima K Watanabe Y Induction of cell migration of neural progenitor cells in vitro by alpha-1 adrenergic receptor and dopamine D1 receptor stimulation Neuroreport 2008 19 793 797 18446092
  122. [126]Gupta MK Papay RS Jurgens CW Gaivin RJ Shi T Doze VA Perez DM alpha1-Adrenergic receptors regulate neurogenesis and gliogenesis Mol Pharmacol 2009 76 314 326 19487244 PMC2713124
  123. [127]Zuscik MJ Sands S Ross SA Waugh DJ Gaivin RJ Morilak D Perez DM Overexpression of the alpha1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy Nat Med 2000 6 1388 1394 11100125
  124. [128]Stone EA Zhang Y Rosengarten H Yeretsian J Quartermain D Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice Neuroscience 1999 94 1245 1252 10625064
  125. [129]Stone EA Rosengarten H Lin Y Quartermain D Pharmacological blockade of brain alpha1-adrenoceptors as measured by ex vivo [3H]prazosin binding is correlated with behavioral immobility Eur J Pharmacol 2001 420 97 102 11408030
  126. [130]Grenhoff J Svensson TH Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area Eur J Pharmacol 1993 233 79 84 8097162
  127. [131]Berretta N Bernardi G Mercuri NB Alpha(1)-adrenoceptormediated excitation of substantia nigra pars reticulata neurons Neuroscience 2000 98 599 604 10869853
  128. [132]Stone EA Lin Y Itteera A Quartermain D Pharmacological evidence for the role of central alpha 1B-adrenoceptors in the motor activity and spontaneous movement of mice Neuropharmacology 2001 40 254 261 11114404
  129. [133]Knauber J Müller WE Decreased exploratory activity and impaired passive avoidance behaviour in mice deficient for the alpha(1b)-adrenoceptor Eur Neuropsychopharmacol 2000 10 423 427 11115730
  130. [134]Drouin C Darracq L Trovero F Blanc G Glowinski J Cotecchia S Tassin JP Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates J Neurosci 2002 22 2873 2884 11923452 PMC6758308
  131. [135]Auclair A Cotecchia S Glowinski J Tassin JP D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release J Neurosci 2002 22 9150 9154 12417637 PMC6758052
  132. [136]Wada T Hasegawa Y Ono H Characterization of alpha1- adrenoceptor subtypes in facilitation of rat spinal motoneuron activity Eur J Pharmacol 1997 340 45 52 9527505
  133. [137]Papay R Zuscik MJ Ross SA Yun J McCune DF Gonzalez-Cabrera P Gaivin R Drazba J Perez DM Mice expressing the alpha(1B)-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation J Neurochem 2002 83 623 634 12390524
  134. [138]Collette KM Hurtt CC Perez DM Doze VA Chronic α1A-adrenergic receptor stimulation increases lifespan in mice FASEB J 2011 in press
  135. [139]Pussinen R Nieminen S Koivisto E Haapalinna A Riekkinen P Sr Sirvio J Enhancement of intermediate-term memory by an alpha-1 agonist or a partial agonist at the glycine site of the NMDA receptor Neurobiol Learn Mem 1997 67 69 74 9013503
  136. [140]Pussinen R Sirviö J Minor role for alpha1-adrenoceptors in the facilitation of induction and early maintenance of long-term potentiation in the CA1 field of the hippocampus J Neurosci Res 1998 51 309 315 9486766
  137. [141]Miyashita T Williams CL Enhancement of noradrenergic neurotransmission in the nucleus of the solitary tract modulates memory storage processes Brain Res 2003 987 164 175 14499960
  138. [142]Arnsten AFT Ordway GA Schwartz MA Frazer A Norepinephrine and cognitive disorders Brain Norepinephrine 2007 Cambridge Cambridge University Press 408 435
  139. [143]Mao ZM Arnsten AF Li BM Local infusion of an alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys Biol Psychiatry 1999 46 1259 1265 10560031
  140. [144]Gibbs ME Summers RJ Stimulation of alpha1-adrenoceptors inhibits memory consolidation in the chick Eur J Neurosci 2001 14 1369 1376 11703465
  141. [146]Hong CJ Wang YC Liu TY Liu HC Tsai SJ A study of alphaadrenoceptor gene polymorphisms and Alzheimer disease J Neural Transm 2001 108 445 450 11475011
  142. [147]Klingner M Apelt J Kumar A Sorger D Sabri O Steinbach J Scheunemann M Schliebs R Alterations in cholinergic and noncholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology Int J Dev Neurosci 2003 21 357 369 14599482
  143. [148]Lapiz MD Morilak DA Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability Neuroscience 2006 137 1039 1049 16298081
  144. [149]Kalaria RN Characterization of [125I]HEAT binding to alpha 1-receptors in human brain: assessment in aging and Alzheimer’s disease Brain Res 1989 501 287 294 2555022
  145. [150]Shimohama S Taniguchi T Fujiwara M Kameyama M Biochemical characterization of alpha-adrenergic receptors in human brain and changes in Alzheimer-type dementia J Neurochem 1986 47 1295 1301 3018166
  146. [151]Szot P White SS Greenup JL Leverenz JB Peskind ER Raskind MA Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: evidence of compensatory changes Neuroscience 2007 146 471 480 17324522 PMC3399726
  147. [152]Izumi Y Zorumski CF Norepinephrine promotes long-term potentiation in the adult rat hippocampus in vitro Synapse 1999 31 196 202 10029237
  148. [153]Katsuki H Izumi Y Zorumski CF Noradrenergic regulation of synaptic plasticity in the hippocampal CA1 region J Neurophysiol 1997 77 3013 3020 9212253
  149. [154]Scheiderer CL Dobrunz LE McMahon LL Novel form of longterm synaptic depression in rat hippocampus induced by activation of alpha 1 adrenergic receptors J Neurophysiol 2004 91 1071 1077 14573563
  150. [155]Stone EA Quartermain D Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression Biol Psychiatry 1999 46 1287 1300 10560034
  151. [156]Doze VA Handel EM Jensen KA Darsie B Luger EJ Haselton JR Talbot JN Rorabaugh BR Alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse Brain Res 2009 1285 148 157 19540213 PMC2720445
  152. [159]Aroniadou-Anderjaska V Qashu F Braga MF Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders Amino Acids 2007 32 305 315 17048126
  153. [160]Weinshenker D Szot P The role of catecholamines in seizure susceptibility: new results using genetically engineered mice Pharmacol Ther 2002 94 213 233 12113799
  154. [161]Giorgi FS Pizzanelli C Biagioni F Murri L Fornai F The role of norepinephrine in epilepsy: from the bench to the bedside Neurosci Biobehav Rev 2004 28 507 524 15465138
  155. [162]Löscher W Czuczwar SJ Comparison of drugs with different selectivity for central alpha 1-and alpha 2-adrenoceptors in animal models of epilepsy Epilepsy Res 1987 1 165 172 2848694
  156. [163]Neuman RS Suppression of penicillin-induced focal epileptiform activity by locus ceruleus stimulation: mediation by an alpha 1-adrenoceptor Epilepsia 1986 27 359 366 3013608
  157. [164]Wu HQ Tullii M Samanin R Vezzani A Norepinephrine modulates seizures induced by quinolinic acid in rats: selective and distinct roles of alpha-adrenoceptor subtypes Eur J Pharmacol 1987 138 309 318 3040437
  158. [165]Stanton PK Noradrenergic modulation of epileptiform bursting and synaptic plasticity in the dentate gyrus Epilepsy Res Suppl 1992 7 135 150 1334659
  159. [166]Ferry B Magistretti PJ Pralong E Noradrenaline modulates glutamate-mediated neurotransmission in the rat basolateral amygdale in vitro Eur J Neurosci 1997 9 1356 1364 9240393
  160. [167]Yan QS Dailey JW Steenbergen JL Jobe PC Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study Brain Res 1998 780 199 209 9507130
  161. [168]Weinshenker D Szot P Miller NS Palmiter RD Alpha(1) and beta(2) adrenoreceptor agonists inhibit pentylenetetrazoleinduced seizures in mice lacking norepinephrine J Pharmacol Exp Ther 2001 298 1042 1048 11504801
  162. [169]Gellman RL Aghajanian GK Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons Brain Res 1993 600 63 73 8422591
  163. [170]Braga MF Aroniadou-Anderjaska V Manion ST Hough CJ Li H Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala Neuropsychopharmacology 2004 29 45 58 14532911
  164. [171]Alreja M Liu W Noradrenaline induces IPSCs in rat medial septal/diagonal band neurons: involvement of septohippocampal GABAergic neurons J Physiol (Lond) 1996 494 Pt 1 201 215 8814616 PMC1160624
  165. [172]Kawaguchi Y Shindou T Noradrenergic excitation and inhibition of GABAergic cell types in rat frontal cortex J Neurosci 1998 18 6963 6976 9712665 PMC6792977
  166. [173]Hillman KL Lei S Doze VA Porter JE Alpha-1A adrenergic receptor activation increases inhibitory tone in CA1 hippocampus Epilepsy Res 2009 84 97 109 19201164 PMC2699218
  167. [174]Hillman KL Knudson CA Carr PA Doze VA Porter JE Adrenergic receptor characterization of CA1 hippocampal neurons using real time single cell RT-PCR Brain Res Mol Brain Res 2005 139 267 276 16005103
  168. [175]Hillman KL Doze VA Porter JE Alpha1A-adrenergic receptors are functionally expressed by a subpopulation of cornu ammonis-1 interneurons in rat hippocampus J Pharmacol Exp Ther 2007 321 1062 1068 17337632
  169. [177]Kunieda T Zuscik MJ Boongird A Perez DM Lüders HO Najm IM Systemic overexpression of the alpha 1B-adrenergic receptor in mice: an animal model of epilepsy Epilepsia 2002 43 1324 1329 12423381
  170. [178]Yun J Gaivin RJ McCune DF Boongird A Papay RS Ying Z Gonzalez-Cabrera PJ Najm I Perez DM Gene expression profile of neurodegeneration induced by alpha1B-adrenergic receptor overactivity: NMDA/GABAA dysregulation and apoptosis Brain 2003 126 2667 2681 12937073
  171. [179]Pizzanelli C Lazzeri G Fulceri F Giorgi FS Pasquali L Cifelli G Murri L Fornai F Lack of alpha 1b-adrenergic receptor protects against epileptic seizures Epilepsia 2009 50 Suppl 1 59 64 19125850
  172. [181]Cohen BM Lipinski JF In vivo potencies of antipsychotic drugs in blocking α1-noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action Life Sci 1986 147 1194 1198 2879204
  173. [182]Baldessarini RJ Huston-Lyons D Campbell A Marsh E Cohen BM Do central antiadrenergic actions contribute to the atypical properties of clozapine? Br J Psychiatry Suppl 1992 12 16 1418884
  174. [183]Saiz PA Susce MT Clark DA Kerwin RW Molero P Arranz MJ de Leon J An investigation of the alpha1A-adrenergic receptor gene and antipsychotic-induced side-effects Hum Psychopharmacol 2008 23 107 114 17972277
  175. [184]Ma J Ye N Cohen BM Expression of noradrenergic alpha1, serotoninergic 5HT2a and dopaminergic D2 receptors on neurons activated by typical and atypical antipsychotic drugs Prog Neuropsychopharmacol Biol Psychiatry 2006 30 647 657 16487641
  176. [185]Sleight AJ Koek W Bigg DC Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors Eur J Pharmacol 1993 238 407 410 7691623
  177. [186]Cahir M King DJ Antipsychotics lack alpha 1A/B adrenoceptor subtype selectivity in the rat Eur Neuropsychopharmacol 2005 15 231 234 15695070
  178. [187]Cahir M Mawhinney T King DJ Differential region-specific regulation of central alpha 1-adrenoceptor binding following chronic haloperidol and clozapine administration in the rat Psychopharmacology (Berl) 2004 172 196 201 14534772
  179. [188]Keilhoff G Grecksch G Bernstein HG Roskoden T Becker A Risperidone and haloperidol promote survival of stem cells in the rat hippocampus Eur Arch Psychiatry Clin Neurosci 2010 260 151 162 19579000
  180. [189]Clark DA Arranz MJ Mata I Lopéz-Ilundain J Pérez-Nievas F Kerwin RW Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/ schizoaffective disorder in a Spanish isolate population Biol Psychiatry 2005 58 435 439 16043131
  181. [190]Manji HK McNamara R Chen G Lenox RH Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness Aust N Z J Psychiatry 1999 Suppl S65 S83 10622182
  182. [191]Volk DW Eggan SM Lewis DA Alterations in metabotropic glutamate receptor 1a and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia Am J Psychiatry 2010 167 1489 1498 20889653 PMC2997877
  183. [192]Mirnics K Middleton FA Stanwood GD Lewis DA Levitt P Disease-specific changes in regulator of G-protein signaling-4 (RGS4) expression in schizophrenia Mol Psychiatry 2001 6 293 301 11326297
  184. [193]Prasad KM Chowdari KV Nimgaonkar VL Talkowski ME Lewis DA Keshavan MS Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients Mol Psychiatry 2005 10 213 219 15381923
  185. [194]Erdely HA Tamminga CA Roberts RC Vogel MW Regional alterations in RGS4 protein in schizophrenia Synapse 2006 59 472 479 16565965
  186. [195]Ding L Hegde AN Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients Biol Psychiatry 2009 65 541 545 19041089
  187. [196]Hague C Bernstein LS Ramineni S Chen Z Minneman KP Hepler JR Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop J Biol Chem 2005 280 27289 27295 15917235

Cited by

Sorted by citations

Authors
Perez, D. M., & Doze, V. A.
Affiliations
  • Cleveland Clinic (US)
  • University of North Dakota (US)
Corresponding author
Perez, Dianne M.
Venue
Journal of Receptors and Signal Transduction
Published
2011-02-21
Volume
31
Issue
2
Pages
98-110
ISSN
  • 1079-9893 (ISSN-L)
  • 1532-4281
OpenAlex
W2016991385
Cited by
59
References
3
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 8 · 2022: 3 · 2021: 8 · 2020: 8 · 2019: 1 · 2018: 5 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 3 · 2013: 5 · 2012: 4
FWCI
0.35
Type
journal article
Language
en
Open access
Locations
  • Journal of Receptors and Signal Transduction (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL098279)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
alpha1-adrenoceptors, cardiac hypertrophy, heart failure, apoptosis, ischemic preconditioning, neurogenesis, neurodegeneration, neuroplasticity, depression, anxiety, epilepsy, mental illness, sympathetic nervous system, neuroprotection
MeSH terms
Animals, Humans, Myocardium, Neurons, Receptors, Adrenergic, alpha-1, Cytoprotection, Protective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review